Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-06
1998-10-06
Kulkosky, Peter F.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
424824, 424825, 424885, 424921, A61K 3152
Patent
active
058176624
ABSTRACT:
Compounds and pharmaceutical compositions thereof comprise the formula:
REFERENCES:
patent: 3245994 (1966-04-01), Klingler et al.
patent: 3422107 (1969-01-01), Mohler et al.
patent: 3737433 (1973-06-01), Mohler et al.
patent: 4061753 (1977-12-01), Bodor et al.
patent: 4144340 (1979-03-01), Offermanns et al.
patent: 4275064 (1981-06-01), Bodor et al.
patent: 4279992 (1981-07-01), Boguslaski et al.
patent: 4299832 (1981-11-01), Brown et al.
patent: 4374837 (1983-02-01), Favier et al.
patent: 4515795 (1985-05-01), Hinze et al.
patent: 4542137 (1985-09-01), Kiessing et al.
patent: 4558051 (1985-12-01), Sunshine et al.
patent: 4565817 (1986-01-01), Korbonits et al.
patent: 4576947 (1986-03-01), Hinze et al.
patent: 4618612 (1986-10-01), Baglioni
patent: 4636507 (1987-01-01), Kreutzer et al.
patent: 4784994 (1988-11-01), Romer et al.
patent: 4833146 (1989-05-01), Gebert et al.
patent: 4845081 (1989-07-01), Sloan
patent: 4965271 (1990-10-01), Mandell et al.
patent: 5039666 (1991-08-01), Novick, Jr.
patent: 5096906 (1992-03-01), Mandell et al.
patent: 5118500 (1992-06-01), Hanel et al.
patent: 5126340 (1992-06-01), Tseng et al.
patent: 5196439 (1993-03-01), Sugimoto et al.
patent: 5247086 (1993-09-01), Cain et al.
patent: 5272153 (1993-12-01), Mandell et al.
patent: B13737433 (1987-03-01), Mohler et al.
Bianco et al., Blood, 76: Supplement 1 (522), p. 133a, "Pentoxifylline (PTX) and GM-CSF Decrease Tumor Necrosis Factor-ALPHA (TNF-.alpha.) Levels in Patients Undergoing Allogeneic Bond Marrow Transplantation (BMT)", 1990.
Bianco et al., Blood, 78:5, pp. 1205-1211, "Phase I-II Trial of Pentoxifylline for the Prevention of Transplant-Related Toxicities Following Bone Marrow Transplantation", Sep. 1991.
Bursten et al., The Journal of Biological Chemistry, vol. 266, No. 31, pp. 20732-20743, "Interleukin-1 Rapidly Stimulates Lysophosphatidate Acyltransferase and Phosphatidate Phosphohydrolase activities in Human Mesangial Cells", Nov., 1991.
Davis et al., Applied Environment Microbial., 48:2, pp. 327-331, "Microbial Models of Mammalian Metabolism: Microbial Reduction and Oxidatin of Pentoxifylline", Aug. 1984.
Ridder., Chemical Abstracts, vol. 60, col. 15892, "Derivatives of dialkylxanthines", Jan. 1964.
Singer et al., Bone Marrow Transplantation, 10:19, pp. 19-25, "Effect of Methylxanthine Derivatives on T Cell Activation", 1992.
Adams et al., Jour. Amer. Chem. Society, vol. 67, 1945, pp. 1271-1273, "Heterocyclic Basic Compounds".
Klein J. Peter
Leigh Alistair J.
Underiner Gail E.
Cell Therapeutics Inc.
Kulkosky Peter F.
LandOfFree
Substituted amino alkyl compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted amino alkyl compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted amino alkyl compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-77384